Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · fourth_quarter · Q4
Discussions related to National Institutes of Health (NIH) and Food and Drug Administration (FDA) funding Discussions related to Potential Health Care Reform Legislation in the 115th Congress; provisions related to protections for people with pre-existing conditions, Medicaid financing, Medicaid expansion, high risk pools, annual and lifetime caps on coverage, consumer directed plans, and protections for provisions pertinent to the Cystic Fibrosis community Discussions related to general health care reform issues and considerations relative to the Cystic Fibrosis community in response to Speaker Ryans Better Way Plan and Representative Prices Empowering Patients First Act; provisions related to coverage for pre-existing conditions, high risk pools, consumer directed health plans, annual and lifetime coverage caps, Medicaid financing and expansion Discussions related to the Affordable Care Act Reform Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Advancing Hope Act of 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Next Generation Researchers Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Advancing Targeted Therapies for Rare Diseases Act of 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Improving Health Information Technology Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
S. 2689: REGROW Act; all provisions of the bill S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding Discussions related to FY17 Labor, Health and Human Services Appropriations; provisions related to National Institutes of Health funding
FDA and NIH Workforce Authorities Modernization Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Advancing Precision Medicine Act of 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Medicare Home Infusion Site of Care Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
National Defense Authorization Act for Fiscal Year 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
S. 2689: REGROW Act; all provisions of the bill S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding Discussions related to FY17 Labor, Health and Human Services Appropriations; provisions related to National Institutes of Health funding
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Consolidated Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Consolidated Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 6: 21st Century Cures Act; provisions on drug development and disease research HR 209: Ensuring Access to Clinical Trials Act of 2015; provisions related to access Not Yet Introduced: Discussions related to HELP Innovation for Healthier Americans legislation; provisions on drug development and disease research Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access to military health care center for civilians with Cystic Fibrosis
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
All provisions of the Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization General discussions regarding 21st Century Cures Initiative General discussions regarding Innovation for Healthier Americans Initiative
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative Innovation for Healthier Americans Initiative
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Bill Not Yet Introduced: Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & National Institutes of Health funding, laboratory developed tests, pathways for approval of drugs, clinical trial design, & biomedical research Bill Not Yet Introduced: Discussions related to Prescription Drug User Fee Act (PDUFA) VI; provisions related to rare diseases, pathways for drugs, expertise in review of rare treatments Bill Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/ S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & the National Institutes of Health funding and regulations
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
HR 6: 21st Century Cures Act; provisions on drug development and disease research HR 209: Ensuring Access to Clinical Trials Act of 2015; provisions related to access Not Yet Introduced: Discussions related to HELP Innovation for Healthier Americans legislation; provisions on drug development and disease research Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access to military health care center for civilians with Cystic Fibrosis
Medicare Home Infusion Site of Care Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/ S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & the National Institutes of Health funding and regulations
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
All provisions of the Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization General discussions regarding 21st Century Cures Initiative General discussions regarding Innovation for Healthier Americans Initiative
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Bill Not Yet Introduced: Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & National Institutes of Health funding, laboratory developed tests, pathways for approval of drugs, clinical trial design, & biomedical research Bill Not Yet Introduced: Discussions related to Prescription Drug User Fee Act (PDUFA) VI; provisions related to rare diseases, pathways for drugs, expertise in review of rare treatments Bill Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative Innovation for Healthier Americans Initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
Medicare Home Infusion Site of Care Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Funding for the National Institutes of Health (NIH) HR1281-Newborn Screening Saves Lives Reauthorization Act HR4930-ACE Kids Act Implementation of S.1674-Improving Access to Clinical Trials Act Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR1281-Newborn Screening Saves Lives Reauthorization Act Reauthorization of S.1674-Improving Access to Clinical Trials Act Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Funding for the National Institutes of Health (NIH) HR1281-Newborn Screening Saves Lives Reauthorization Act HR4930-ACE Kids Act Implementation of S.1674-Improving Access to Clinical Trials Act Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR1281-Newborn Screening Saves Lives Reauthorization Act Reauthorization of S.1674-Improving Access to Clinical Trials Act Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Funding for the National Institutes of Health (NIH) HR1281-Newborn Screening Saves Lives Reauthorization Act HR4930-ACE Kids Act Implementation of S.1674-Improving Access to Clinical Trials Act Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · third_quarter · Q3
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · second_quarter · Q2
S. 2689: REGROW Act; all provisions of the bill S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding Discussions related to FY17 Labor, Health and Human Services Appropriations; provisions related to National Institutes of Health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · fourth_quarter · Q4
HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and the National Institutes of Health funding HR 3020/S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions related to the National Institutes of Health funding HR 3049/S. 1800: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; provisions related to Food and Drug Administration funding
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
HR 209/ S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & the National Institutes of Health funding and regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · third_quarter · Q3
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Bill Not Yet Introduced: Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & National Institutes of Health funding, laboratory developed tests, pathways for approval of drugs, clinical trial design, & biomedical research Bill Not Yet Introduced: Discussions related to Prescription Drug User Fee Act (PDUFA) VI; provisions related to rare diseases, pathways for drugs, expertise in review of rare treatments Bill Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · second_quarter · Q2
HR 6: 21st Century Cures Act; provisions on drug development and disease research HR 209: Ensuring Access to Clinical Trials Act of 2015; provisions related to access Not Yet Introduced: Discussions related to HELP Innovation for Healthier Americans legislation; provisions on drug development and disease research Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access to military health care center for civilians with Cystic Fibrosis
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · first_quarter · 1A
All provisions of the Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization General discussions regarding 21st Century Cures Initiative General discussions regarding Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · first_quarter · Q1
Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · fourth_quarter · Q4
HR1281-Newborn Screening Saves Lives Reauthorization Act Reauthorization of S.1674-Improving Access to Clinical Trials Act Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · third_quarter · Q3
Funding for the National Institutes of Health (NIH) HR1281-Newborn Screening Saves Lives Reauthorization Act HR4930-ACE Kids Act Implementation of S.1674-Improving Access to Clinical Trials Act Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · 2A
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · 2A
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · Q2
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE